Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Peringkat dalam Saham #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Harga Saham
$62.83
Kapitalisasi Pasar
$93.23B
Perubahan (1 hari)
-9.17%
Perubahan (1 tahun)
-31.36%
Negara
US
Perdagangan Boston Scientific Corporation (BSX)

Kategori

Laba untuk Boston Scientific Corporation (BSX)
Laba pada Dec 2025 TTM: $3.39B
Menurut laporan keuangan terbaru dari Boston Scientific Corporation, laba saat ini perusahaan adalah $3.39B. Pada tahun 2024, perusahaan memperoleh laba sebesar $2.28B, peningkatan dibandingkan laba tahun 2023 sebesar $1.99B. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Boston Scientific Corporation dari 2000 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $3.39B 0.00%
2025 $3.39B 48.33%
2024 $2.28B 14.96%
2023 $1.99B 73.97%
2022 $1.14B 6.04%
2021 $1.08B -1,462.03%
2020 $-79.00M -111.50%
2019 $687.00M -51.69%
2018 $1.42B 52.41%
2017 $933.00M 427.12%
2016 $177.00M -127.23%
2015 $-650.00M 27.70%
2014 $-509.00M 128.25%
2013 $-223.00M -94.57%
2012 $-4.11B -739.72%
2011 $642.00M -160.40%
2010 $-1.06B -18.73%
2009 $-1.31B -35.60%
2008 $-2.03B 256.94%
2007 $-569.00M -83.90%
2006 $-3.54B -496.75%
2005 $891.00M -40.36%
2004 $1.49B 132.35%
2003 $643.00M 17.12%
2002 $549.00M 1,147.73%
2001 $44.00M -91.65%
2000 $527.00M 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$8.47B 150.10%
US
$4.51B 33.35%
US
$5.56B 64.38%
IE
$5.56B 64.34%
IE
$3.13B -7.48%
DE